J0752 – Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0752
- Long description
- Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- Short description
- Hiv prep, oral lenacapavir
- Pricing indicator
57Other carrier priced- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2025
- Last change
- October 1, 2025 – No change
Frequently asked questions
What is HCPCS code J0752?
J0752 is a HCPCS Level II code for oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv).
Does Medicare cover J0752?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0740 – Injection, cidofovir, 375 mg
- J0741 – Injection, cabotegravir and rilpivirine, 2mg/3mg
- J0742 – Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
- J0743 – Injection, cilastatin sodium; imipenem, per 250 mg
- J0744 – Injection, ciprofloxacin for intravenous infusion, 200 mg
- J0745 – Injection, codeine phosphate, per 30 mg
- J0750 – Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- J0751 – Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- J0759 – Injection, clevidipine butyrate, 1 mg
- J0760 – Injection, colchicine, per 1 mg
- J0770 – Injection, colistimethate sodium, up to 150 mg
- J0775 – Injection, collagenase, clostridium histolyticum, 0.01 mg
- J0780 – Injection, prochlorperazine, up to 10 mg
- J0791 – Injection, crizanlizumab-tmca, 5 mg
- J0795 – Injection, corticorelin ovine triflutate, 1 microgram
- J0799 – Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.